首页> 外国专利> Compound of formula I and its uses, activity inhibition methods and monoamine receptor activation inhibition method, treatment methods, genetic polymorphism identification method and patient identification method

Compound of formula I and its uses, activity inhibition methods and monoamine receptor activation inhibition method, treatment methods, genetic polymorphism identification method and patient identification method

机译:式I化合物及其用途,活性抑制方法和单胺受体活化抑制方法,治疗方法,遗传多态性鉴定方法和患者鉴定方法

摘要

"COMPOUND FORMULA I AND ITS USES, ACTIVITY INHIBIT METHOD AND INHIBIT METHOD OF A MONOAMINE RECEIVER, TREATMENT METHODS, POLYMORPHISTIC IDENTIFICATION METHOD AND METHOD DEPTH The present invention relates to spiroazacyclic compounds as monoamine receptor modulators; compositions comprising them, methods of inhibiting monoamine receptor activity with said compounds; methods of treating a monoamine receptor-associated disease condition using said compounds; and methods for identifying appropriate patients for treatment using said compounds.
机译:“化合物式I及其用途,单胺受体的活性抑制方法和抑制方法,治疗方法,多态性鉴定方法和方法深度本发明涉及作为单胺受体调节剂的螺氮杂环化合物;包含它们的组合物;抑制单胺受体活性的方法。所述化合物的用途;使用所述化合物治疗与单胺受体相关的疾病的方法;以及使用所述化合物鉴定合适的患者进行治疗的方法。

著录项

  • 公开/公告号BR0215429A

    专利类型

  • 公开/公告日2004-12-14

    原文格式PDF

  • 申请/专利权人 ACADIA PHARMACEUTICALS INC.;

    申请/专利号BR20020215429

  • 发明设计人 NATHALIE SCHLIENGER;

    申请日2002-12-23

  • 分类号C07D471/10;C07D498/10;C07D513/10;C07D519/00;A61K31/438;A61K31/537;A61P25/00;A61P9/00;

  • 国家 BR

  • 入库时间 2022-08-21 22:18:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号